Skip to main content

. 1989 Jan 14;298(6666):93. doi: 10.1136/bmj.298.6666.93

Life threatening interaction between tamoxifen and warfarin.

P Tenni ¹, D L Lalich ¹, M J Byrne ¹

PMCID: PMC1835395 PMID: 2493305

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Coezy E., Borgna J. L., Rochefort H. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res. 1982 Jan;42(1):317–323. [PubMed] [Google Scholar]
Fabian C., Tilzer L., Sternson L. Comparative binding affinities of tamoxifen, 4-hydroxytamoxifen, and desmethyltamoxifen for estrogen receptors isolated from human breast carcinoma: correlation with blood levels in patients with metastatic breast cancer. Biopharm Drug Dispos. 1981 Oct-Dec;2(4):381–390. doi: 10.1002/bdd.2510020407. [DOI] [PubMed] [Google Scholar]
Furr B. J., Jordan V. C. The pharmacology and clinical uses of tamoxifen. Pharmacol Ther. 1984;25(2):127–205. doi: 10.1016/0163-7258(84)90043-3. [DOI] [PubMed] [Google Scholar]
Kelly J. G., O'Malley K. Clinical pharmacokinetics of oral anticoagulants. Clin Pharmacokinet. 1979 Jan-Feb;4(1):1–15. doi: 10.2165/00003088-197904010-00001. [DOI] [PubMed] [Google Scholar]
Lodwick R., McConkey B., Brown A. M. Life threatening interaction between tamoxifen and warfarin. Br Med J (Clin Res Ed) 1987 Oct 31;295(6606):1141–1141. doi: 10.1136/bmj.295.6606.1141-b. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES